Jubilant Pharmova Q4 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
1,113.95-27.25 (-2.39%)
Volume16.94 K
Updated: Mon 25 Nov, 2024 | 15:29:39
NSE
1,113-25.50 (-2.24%)
Volume2.28 L
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,094.10
1,160.80
52-Wk: 408.60
1,309.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jubilant Pharmova Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 1,758.601,552.51-%1,678.00-%
    Selling/ General/ Admin Expenses Total 555.00567.94-%534.30-%
    Depreciation/ Amortization 101.0094.28-%271.23-%
    Other Operating Expenses Total 404.80360.62-%394.71-%
    Total Operating Expense 1,757.101,500.91-%1,730.01-%
    Operating Income 1.5051.60-%-52.01-%
    Net Income Before Taxes -53.708.73-%-86.41-%
    Net Income -58.60-15.67-%-97.84-%
    Diluted Normalized EPS 3.22-0.98-%-6.12-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts